Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.
about
Recombinant growth hormone therapy for cystic fibrosis in children and young adultsRecombinant growth hormone therapy for cystic fibrosis in children and young adultsRecombinant growth hormone therapy for cystic fibrosis in children and young adultsInterventions for growth failure in childhood Crohn's diseaseThe functional genomic response of developing embryonic submandibular glands to NF-kappa B inhibitionHormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1Immune Dysfunction as a Cause and Consequence of MalnutritionPhysical Exercise as Therapy for FrailtyGrowth factors, nutrient signaling, and cardiovascular agingInterleukin-6 myokine signaling in skeletal muscle: a double-edged sword?Growth abnormalities in children with type 1 diabetes, juvenile chronic arthritis, and asthmaType I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaMuscle-derived interleukin-6: possible biological effectsSkeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exerciseMice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1.The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta.Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study.Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment StrategiesAssessment of Growth Disturbance in Japanese Children with IBDResearch, policy, and programmatic considerations from the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1βElectrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial.Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children.Chronic inflammatory bowel disease in children: a complex problem in management.Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardationTestosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults.Skeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis.IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-scoreGrowth problems in children with IBD.A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.Exercise, diet, and childhood obesity: the GH-IGF-I connection.Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidenceStunting is characterized by chronic inflammation in Zimbabwean infantsSex differences in statural growth impairment in Crohn's disease: role of IGF-1.Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants.The relationship between serum insulin-like growth factor I levels and ischemic stroke risk
P2860
Q24187892-955F828A-ADA3-432D-B8A3-02FAAE233044Q24202203-B0047C9A-7857-40C7-A5BC-CAB86962B1B6Q24236229-1BBFD4A3-FAF3-4D6C-A24A-72F1B97F7D8CQ24246404-B84BC0E9-ED8C-4255-995D-21330E97E9E7Q24794871-353A1D74-10AD-439D-BEB6-4159E1811FC5Q24804802-9712328B-8E82-41E1-BFAD-24C6FB09DBE1Q26745474-753131F3-C309-4BB8-A308-59241E6E574DQ26777445-8557B8F4-01DE-4A73-93DE-E6B3E46FA185Q26852243-8CDAA5E9-D0F8-47DE-AFC5-EE5F1B0614FAQ26866208-63CC7B7F-D8BF-4F91-B124-FDC2EADA6D3EQ27002961-D4F2E412-838B-4887-B6DE-9E51EAB96E4FQ28080514-BB059780-DF5F-411F-AADE-556EE7FB41FCQ28361640-B4F49B53-45BB-421C-8718-5836C40206CFQ28566793-7447D093-7F81-404F-BE33-27B066236AB2Q30252705-07032A08-FA7F-4DEE-97E8-5A40A713A6E5Q33239303-55E18F48-47A9-4CF7-9FA0-E1B3863000AEQ33559252-23BE2095-C27F-48FF-B0DB-F407BEA5728BQ33780616-71AD3527-ABAF-44A6-BAD1-638A1994F7ECQ33829302-BBBF77BA-4E3E-4576-82AF-6B72B80B6180Q33852313-E1FB854E-FE15-45DA-B9A7-62460B0D4015Q33913108-7625D3AE-C2F7-41A0-8243-45477D32130EQ33919314-652796C6-0991-4996-8382-A9A24D13F692Q33920812-96EF16F1-9777-4146-AAFC-2187E75DB231Q33941702-75AACC17-8B16-46A2-BBFF-FE669BF31A2FQ33978006-6E2F6EB8-40DA-4BEF-9CAD-FF1E06B3A5DEQ33988934-FCACEF91-7DA6-49A6-BA77-8B21420E84D8Q34073323-F69A7B57-CC3A-4933-8EDF-DADA75DC2AF1Q34137976-43C4DBBD-B6A0-4175-86E4-F094F1FCCE2EQ34310898-41A52A53-E6CA-4C59-8E20-6F276FA51B6EQ34420623-B3EA3783-F843-4FD7-BBE6-2AB112246E4AQ34426164-CDA090B3-538A-495E-A042-DD464D0E0134Q34632661-DBDA73BA-5835-4E22-8A65-A1DAD2CC28ECQ34646212-8B03A34D-E0EA-406F-AB7D-AAF07BB16720Q34716084-0B97C38B-6CD7-4782-AC50-C51B55F90CB1Q35099084-2FCA60E8-1BAE-430C-82B6-3FDE6587DCB6Q35099463-269AD855-5C6C-407F-9E87-1E2531A58AF1Q35106293-7BCDE627-F063-4FD2-BA74-AA621FB6688EQ35107341-D5B8FF8C-64D2-4453-90CF-691F229E604AQ35140513-301980CF-1A41-4046-ABC7-D195438F775AQ35146896-EEADDD2F-57DA-4F7C-8D8F-0F5BB21DD4ED
P2860
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@en
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@nl
type
label
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@en
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@nl
prefLabel
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@en
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@nl
P2093
P2860
P921
P356
P1476
Interleukin 6 causes growth im ...... ren with chronic inflammation.
@en
P2093
Ciliberto G
De Benedetti F
P2860
P304
P356
10.1172/JCI119207
P407
P50
P577
1997-02-01T00:00:00Z